CRPS Differential Diagnosis: Ruling Out Mimics of Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) is a chronic pain condition characterized by disproportionate pain, sensory, autonomic, and motor changes, typically following an injury. Diagnosing CRPS can be challenging due to its varied presentation and the lack of definitive diagnostic tests. The Budapest Criteria provide a framework for diagnosis, emphasizing clinical signs and symptoms after excluding other conditions. This process of exclusion, known as differential diagnosis, is crucial to accurately identify CRPS and ensure appropriate management. This article delves into the differential diagnosis of CRPS, outlining key conditions that can mimic its features and how clinicians can differentiate between them.

Introduction

Complex Regional Pain Syndrome (CRPS), previously known as reflex sympathetic dystrophy (RSD) and causalgia, is a debilitating neuropathic pain disorder. It is defined by persistent pain that is out of proportion to the initial injury, accompanied by sensory, motor, and autonomic abnormalities. These abnormalities can include allodynia, hyperalgesia, changes in skin temperature and color, swelling, and motor dysfunction. While the exact cause of CRPS remains unclear, it is thought to involve a complex interplay of inflammatory, immunological, and neurological factors.

[Referencing back to historical context, Ambroise Paré first documented CRPS-like symptoms in the 16th century, and Silas Mitchell further characterized it after the Civil War. The term CRPS and the Budapest Criteria are more recent developments, highlighting the evolving understanding of this condition.]

The diagnosis of CRPS relies primarily on clinical evaluation based on the Budapest Criteria, which emphasize both patient-reported symptoms and observed signs. However, many other conditions can present with overlapping symptoms, making differential diagnosis a critical step in the diagnostic process. Excluding these conditions is essential to avoid misdiagnosis and ensure patients receive the correct treatment. This article will explore the key conditions that should be considered in the differential diagnosis of CRPS.

Etiology of CRPS and Diagnostic Challenges

CRPS can be triggered by various events, most commonly trauma, including fractures, surgery, sprains, and even minor injuries like intravenous line placement. In some cases, CRPS can develop spontaneously without a clear inciting event. Risk factors can include fractures, surgeries, and potentially genetic predispositions. The variability in triggers and the lack of a single, definitive cause contribute to the diagnostic complexity of CRPS.

[It’s important to remember that while fractures and surgeries are common triggers, CRPS can arise from seemingly minor events or even spontaneously, broadening the spectrum of potential patients.]

The Budapest Criteria, established by the International Association for the Study of Pain (IASP), are the most widely used diagnostic tool for CRPS. They offer improved specificity compared to earlier criteria, but CRPS remains a clinical diagnosis of exclusion. This means that clinicians must carefully consider and rule out other conditions that could explain the patient’s symptoms before confirming a diagnosis of CRPS.

Differential Diagnosis of CRPS

The differential diagnosis of CRPS is broad and includes conditions that can mimic its pain, sensory, autonomic, and motor manifestations. These conditions can be broadly categorized and include neurological, vascular, musculoskeletal, and inflammatory disorders.

Neurological Conditions

• Peripheral Neuropathy: Both small and large fiber neuropathies can cause pain, sensory changes (numbness, tingling, burning), and sometimes even autonomic symptoms.
  • Distinguishing from CRPS: Peripheral neuropathy often follows a dermatomal or peripheral nerve distribution, unlike the regional spread of CRPS. Neuropathic pain in peripheral neuropathy may not be as disproportionate as in CRPS. Nerve conduction studies and EMG can help diagnose peripheral neuropathy.
• Nerve Entrapment Syndromes (e.g., Carpal Tunnel Syndrome, Cubital Tunnel Syndrome): These conditions involve nerve compression, leading to pain, numbness, and weakness in a specific nerve distribution.
  • Distinguishing from CRPS: Symptoms are typically localized to the distribution of the entrapped nerve. Provocative tests (e.g., Phalen’s test, Tinel’s sign) and nerve conduction studies can aid in diagnosis. CRPS pain is regional and more diffuse, extending beyond a single nerve distribution.
• Radiculopathy: Nerve root compression in the spine can cause radiating pain, sensory changes, and weakness, often following a dermatomal pattern.
  • Distinguishing from CRPS: Radiculopathy typically presents with pain radiating along a dermatome and may be associated with specific spinal movements or positions. MRI or CT scans of the spine can help identify nerve root compression. CRPS pain is less dermatomal and more regional.
• Multiple Sclerosis (MS): This autoimmune disorder affecting the central nervous system can present with various neurological symptoms, including pain, sensory disturbances, and weakness.
  • Distinguishing from CRPS: MS often involves central nervous system signs and symptoms (e.g., optic neuritis, gait disturbances, bladder dysfunction). Neurological examination and MRI of the brain and spinal cord are crucial for MS diagnosis. CRPS is typically localized to a limb and lacks central nervous system findings.
• Guillain-Barré Syndrome (GBS): An autoimmune disorder affecting the peripheral nerves, GBS can cause weakness, sensory changes, and pain.
  • Distinguishing from CRPS: GBS typically presents with ascending weakness (starting in the legs and moving upwards), areflexia, and can involve respiratory compromise. Nerve conduction studies and CSF analysis are helpful in diagnosing GBS. CRPS is usually localized and does not typically cause widespread, ascending weakness.

Vascular Conditions

• Peripheral Artery Disease (PAD) / Arterial Insufficiency: Reduced blood flow to the extremities can cause pain, coldness, color changes, and trophic changes, mimicking some CRPS features.
  • Distinguishing from CRPS: PAD pain is often exertional (claudication) and relieved by rest. Physical examination may reveal diminished pulses, skin pallor, and coolness. Ankle-brachial index (ABI) and vascular studies (e.g., Doppler ultrasound, angiography) can confirm PAD. CRPS pain is typically continuous and not necessarily related to exertion, and vascular tests would be normal.
• Deep Vein Thrombosis (DVT): A blood clot in a deep vein, often in the leg, can cause pain, swelling, warmth, and color changes.
  • Distinguishing from CRPS: DVT typically presents with acute onset of unilateral leg swelling, pain, warmth, and redness. Doppler ultrasound is the primary diagnostic tool for DVT. CRPS swelling is often more diffuse, and DVT is usually ruled out with ultrasound.
• Erythromelalgia: A rare condition characterized by episodic attacks of redness, warmth, and burning pain in the extremities, often triggered by heat or exertion.
  • Distinguishing from CRPS: Erythromelalgia pain is episodic and clearly triggered by heat or exercise, with visible redness and warmth during attacks. CRPS pain is more persistent, and while temperature changes are present, they are not the primary defining feature of episodic attacks.
• Vasculitis: Inflammation of blood vessels can cause pain, skin changes, and systemic symptoms, depending on the type and location of vasculitis.
  • Distinguishing from CRPS: Vasculitis can present with a wide range of systemic symptoms (e.g., fever, fatigue, weight loss, rash) depending on the organ systems involved. Blood tests (inflammatory markers, autoantibodies) and biopsy of affected tissue can help diagnose vasculitis. CRPS is typically localized and lacks the broad systemic involvement of vasculitis.
• Raynaud’s Phenomenon: Characterized by episodic vasospasm of digital arteries in response to cold or stress, causing color changes (white, blue, red) and numbness or pain in the fingers and toes.
  • Distinguishing from CRPS: Raynaud’s is episodic and triggered by cold or stress, with distinct color changes in the digits. CRPS color changes are more persistent and regional, not limited to digits, and pain is constant, not episodic.

Musculoskeletal Conditions

• Complex Regional Pain Syndrome Mimic (CRPS-Mimic) in athletes: Overuse injuries and compartment syndromes in athletes can sometimes present with pain, swelling, and functional limitations that may resemble early CRPS.
  • Distinguishing from CRPS: CRPS-Mimic typically follows a clear pattern of overuse or exertion. Physical examination and imaging (e.g., MRI) can rule out compartment syndrome or other structural musculoskeletal issues. Symptoms often resolve with rest and appropriate sports injury management. True CRPS persists and worsens despite rest, and presents with more pronounced sensory and autonomic signs.
• Arthritis (Inflammatory or Osteoarthritis): Joint inflammation and degeneration can cause pain, swelling, stiffness, and limited range of motion.
  • Distinguishing from CRPS: Arthritis is typically localized to joints, with joint swelling, tenderness, and radiographic findings (e.g., joint space narrowing, osteophytes). CRPS is regional and extends beyond joint boundaries, with more prominent sensory and autonomic features.
• Tendonitis/Bursitis: Inflammation of tendons or bursae can cause localized pain and swelling around joints.
  • Distinguishing from CRPS: Tendonitis and bursitis pain are typically localized to specific tendons or bursae and are exacerbated by specific movements. Physical examination and sometimes imaging (ultrasound or MRI) can confirm the diagnosis. CRPS pain is more diffuse and regional.
• Myofascial Pain Syndrome: Chronic muscle pain with trigger points can cause regional pain, but lacks the sensory and autonomic features of CRPS.
  • Distinguishing from CRPS: Myofascial pain is primarily muscular, with palpable trigger points and pain referral patterns. It lacks the allodynia, hyperalgesia, and autonomic changes characteristic of CRPS.

Inflammatory and Other Conditions

• Cellulitis: A bacterial skin infection causing redness, warmth, swelling, and pain.
  • Distinguishing from CRPS: Cellulitis presents with clear signs of infection, including fever, chills, and skin warmth and redness that are more pronounced and localized to the infection site. CRPS skin changes are more varied and less overtly infectious.
• Lymphedema: Fluid buildup in tissues due to lymphatic system dysfunction, causing swelling.
  • Distinguishing from CRPS: Lymphedema swelling is typically pitting edema and lacks the pain, sensory, and autonomic features of CRPS. Lymphedema may be secondary to surgery, radiation, or lymphatic disorders.
• Porphyria: A group of genetic disorders affecting heme production, which can sometimes present with neuropathic pain and autonomic dysfunction.
  • Distinguishing from CRPS: Porphyria often has systemic manifestations, including abdominal pain, neurological symptoms, and skin photosensitivity. Urine and blood tests can diagnose porphyria. CRPS is primarily a regional pain syndrome without the broad systemic features of porphyria.
• Hysteria/Conversion Disorder (Functional Neurological Symptom Disorder): Psychological conditions can sometimes manifest with physical symptoms, including pain and functional limitations.
  • Distinguishing from CRPS: Conversion disorder is a diagnosis of exclusion made after thorough medical evaluation rules out organic causes for symptoms. It is important to approach this diagnosis cautiously and ensure a comprehensive assessment, as CRPS itself can have psychological impacts. CRPS is a recognized medical condition with objective signs, while conversion disorder is a psychiatric diagnosis.

Evaluation and Diagnostic Approach

The diagnostic process for CRPS involves a thorough history and physical examination, focusing on the Budapest Criteria. When considering differential diagnoses, the following steps are crucial:

1. Detailed History: Elicit a detailed history of the onset, location, character, and aggravating/relieving factors of pain. Inquire about associated symptoms (sensory, autonomic, motor). Obtain a history of any inciting events, medical conditions, and medications.

2. Comprehensive Physical Examination: Assess for sensory abnormalities (allodynia, hyperalgesia), vasomotor changes (temperature and color asymmetry), sudomotor/edema changes, and motor/trophic changes. Perform a thorough musculoskeletal and neurological examination to assess for other potential conditions.

3. Targeted Investigations: Based on the differential diagnoses considered, order appropriate investigations to rule out other conditions. These may include:

   • Nerve Conduction Studies/EMG: To evaluate for peripheral neuropathy or nerve entrapment.
   • Vascular Studies (ABI, Doppler Ultrasound): To assess for peripheral artery disease or deep vein thrombosis.
   • MRI/CT Scans: To rule out radiculopathy, nerve compression, musculoskeletal injuries, or other structural abnormalities.
   • Blood Tests: To evaluate for inflammatory markers (ESR, CRP), autoantibodies (in vasculitis), or specific conditions like porphyria.
   • Three-Phase Bone Scan: While not specific for CRPS, it can show characteristic patterns of altered bone metabolism. However, it is not used to differentiate CRPS from other conditions but can support the clinical diagnosis when other differentials are excluded.
   • Quantitative Sudomotor Axon Reflex Test (QSART): To assess sudomotor function, but again, it is not specific to CRPS and mainly supportive.
   • Thermography: To detect temperature asymmetry, but lacks specificity for CRPS.

4. Application of Budapest Criteria: Once other conditions are reasonably excluded, apply the Budapest Criteria to assess whether the patient meets the diagnostic criteria for CRPS. Remember that meeting the criteria is necessary but not sufficient for diagnosis; exclusion of other conditions is equally important.

Conclusion

Accurate diagnosis of Complex Regional Pain Syndrome is essential for timely and effective management. The process of differential diagnosis is paramount in distinguishing CRPS from other conditions that can mimic its complex presentation. By systematically considering and excluding neurological, vascular, musculoskeletal, inflammatory, and other potential diagnoses, clinicians can improve diagnostic accuracy and ensure patients receive appropriate care tailored to their specific condition. A thorough clinical evaluation, guided by the Budapest Criteria and supported by targeted investigations, remains the cornerstone of CRPS diagnosis in the context of a broad differential.

References

[Include the same references as the original article, ensuring they are correctly formatted in markdown.]

[1.Stanton-Hicks MD. CRPS: what’s in a name? Taxonomy, epidemiology, neurologic, immune and autoimmune considerations. Reg Anesth Pain Med. 2019 Mar;44(3):376-387. [PubMed: 30777902]]
[2.Goebel A. Complex regional pain syndrome in adults. Rheumatology (Oxford). 2011 Oct;50(10):1739-50. [PubMed: 21712368]]
[3.Smart KM, Wand BM, O’Connell NE. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II. Cochrane Database Syst Rev. 2016 Feb 24;2(2):CD010853. [PMC free article: PMC8646955] [PubMed: 26905470]]
[4.de Rooij AM, Perez RS, Huygen FJ, van Eijs F, van Kleef M, Bauer MC, van Hilten JJ, Marinus J. Spontaneous onset of complex regional pain syndrome. Eur J Pain. 2010 May;14(5):510-3. [PubMed: 19793666]]
[5.Iolascon G, de Sire A, Moretti A, Gimigliano F. Complex regional pain syndrome (CRPS) type I: historical perspective and critical issues. Clin Cases Miner Bone Metab. 2015 Jan-Apr;12(Suppl 1):4-10. [PMC free article: PMC4832406] [PubMed: 27134625]]
[6.Shim H, Rose J, Halle S, Shekane P. Complex regional pain syndrome: a narrative review for the practising clinician. Br J Anaesth. 2019 Aug;123(2):e424-e433. [PMC free article: PMC6676230] [PubMed: 31056241]]
[7.Harden NR, Bruehl S, Perez RSGM, Birklein F, Marinus J, Maihofner C, Lubenow T, Buvanendran A, Mackey S, Graciosa J, Mogilevski M, Ramsden C, Chont M, Vatine JJ. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome. Pain. 2010 Aug;150(2):268-274. [PMC free article: PMC2914601] [PubMed: 20493633]]
[8.Bruehl S. Complex regional pain syndrome. BMJ. 2015 Jul 29;351:h2730. [PubMed: 26224572]]
[9.Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology. 2010 Sep;113(3):713-25. [PubMed: 20693883]]
[10.Galer BS, Henderson J, Perander J, Jensen MP. Course of symptoms and quality of life measurement in Complex Regional Pain Syndrome: a pilot survey. J Pain Symptom Manage. 2000 Oct;20(4):286-92. [PubMed: 11027911]]
[11.Lohnberg JA, Altmaier EM. A review of psychosocial factors in complex regional pain syndrome. J Clin Psychol Med Settings. 2013 Jun;20(2):247-54. [PubMed: 22961122]]
[12.Beerthuizen A, Stronks DL, Van’t Spijker A, Yaksh A, Hanraets BM, Klein J, Huygen FJPM. Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): prospective study on 596 patients with a fracture. Pain. 2012 Jun;153(6):1187-1192. [PubMed: 22386473]]
[13.Brunner F, Bachmann LM, Perez RSGM, Marinus J, Wertli MM. Painful swelling after a noxious event and the development of complex regional pain syndrome 1: A one-year prospective study. Eur J Pain. 2017 Oct;21(9):1611-1617. [PubMed: 28573699]]
[14.Schürmann M, Gradl G, Zaspel J, Kayser M, Löhr P, Andress HJ. Peripheral sympathetic function as a predictor of complex regional pain syndrome type I (CRPS I) in patients with radial fracture. Auton Neurosci. 2000 Dec 28;86(1-2):127-34. [PubMed: 11269918]]
[15.Geertzen JH, Dijkstra PU, Groothoff JW, ten Duis HJ, Eisma WH. Reflex sympathetic dystrophy of the upper extremity–a 5.5-year follow-up. Part I. Impairments and perceived disability. Acta Orthop Scand Suppl. 1998 Apr;279:12-8. [PubMed: 9614810]]
[16.Puchalski P, Zyluk A. Complex regional pain syndrome type 1 after fractures of the distal radius: a prospective study of the role of psychological factors. J Hand Surg Br. 2005 Dec;30(6):574-80. [PubMed: 16126313]]
[17.Rewhorn MJ, Leung AH, Gillespie A, Moir JS, Miller R. Incidence of complex regional pain syndrome after foot and ankle surgery. J Foot Ankle Surg. 2014 May-Jun;53(3):256-8. [PubMed: 24613278]]
[18.Jellad A, Salah S, Ben Salah Frih Z. Complex regional pain syndrome type I: incidence and risk factors in patients with fracture of the distal radius. Arch Phys Med Rehabil. 2014 Mar;95(3):487-92. [PubMed: 24080349]]
[19.Ratti C, Nordio A, Resmini G, Murena L. Post-traumatic complex regional pain syndrome: clinical features and epidemiology. Clin Cases Miner Bone Metab. 2015 Jan-Apr;12(Suppl 1):11-6. [PMC free article: PMC4832405] [PubMed: 27134626]]
[20.Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain. 2003 May;103(1-2):199-207. [PubMed: 12749974]]
[21.de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007 May;129(1-2):12-20. [PubMed: 17084977]]
[22.de Mos M, Huygen FJPM, Stricker CBH, Dieleman JP, Sturkenboom MCJM. The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro-inflammatory pathogenesis of CRPS. Pain. 2009 Apr;142(3):218-224. [PubMed: 19195784]]
[23.An HS, Hawthorne KB, Jackson WT. Reflex sympathetic dystrophy and cigarette smoking. J Hand Surg Am. 1988 May;13(3):458-60. [PubMed: 3379291]]
[24.Goh EL, Chidambaram S, Ma D. Complex regional pain syndrome: a recent update. Burns Trauma. 2017;5:2. [PMC free article: PMC5244710] [PubMed: 28127572]]
[25.Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002 Feb;11(1):47-51. [PMC free article: PMC1781643] [PubMed: 11930962]]
[26.Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005 Aug;116(3):213-219. [PubMed: 15964681]]
[27.Uçeyler N, Eberle T, Rolke R, Birklein F, Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain. 2007 Nov;132(1-2):195-205. [PubMed: 17890011]]
[28.Parkitny L, McAuley JH, Di Pietro F, Stanton TR, O’Connell NE, Marinus J, van Hilten JJ, Moseley GL. Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology. 2013 Jan 01;80(1):106-17. [PMC free article: PMC3589200] [PubMed: 23267031]]
[29.Leis S, Weber M, Schmelz M, Birklein F. Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome. Neurosci Lett. 2004 Apr 15;359(3):163-6. [PubMed: 15050689]]
[30.Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology. 2001 Dec 26;57(12):2179-84. [PubMed: 11756594]]
[31.Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain. 2006 Mar-Apr;22(3):235-9. [PubMed: 16514322]]
[32.Birklein F, Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett. 2008 Jun 06;437(3):199-202. [PubMed: 18423863]]
[33.Kohr D, Singh P, Tschernatsch M, Kaps M, Pouokam E, Diener M, Kummer W, Birklein F, Vincent A, Goebel A, Wallukat G, Blaes F. Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain. 2011 Dec;152(12):2690-2700. [PubMed: 21816540]]
[34.Dubuis E, Thompson V, Leite MI, Blaes F, Maihöfner C, Greensmith D, Vincent A, Shenker N, Kuttikat A, Leuwer M, Goebel A. Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors. Pain. 2014 Nov;155(11):2408-17. [PubMed: 25250722]]
[35.Goebel A, Baranowski A, Maurer K, Ghiai A, McCabe C, Ambler G. Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial. Ann Intern Med. 2010 Feb 02;152(3):152-8. [PubMed: 20124231]]
[36.Sigtermans MJ, van Hilten JJ, Bauer MCR, Arbous SM, Marinus J, Sarton EY, Dahan A. Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain. 2009 Oct;145(3):304-311. [PubMed: 19604642]]
[37.Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain. 2009 Dec 15;147(1-3):107-15. [PubMed: 19783371]]
[38.Maihöfner C, Handwerker HO, Neundörfer B, Birklein F. Patterns of cortical reorganization in complex regional pain syndrome. Neurology. 2003 Dec 23;61(12):1707-15. [PubMed: 14694034]]
[39.Maihöfner C, Handwerker HO, Neundörfer B, Birklein F. Cortical reorganization during recovery from complex regional pain syndrome. Neurology. 2004 Aug 24;63(4):693-701. [PubMed: 15326245]]
[40.Pleger B, Tegenthoff M, Ragert P, Förster AF, Dinse HR, Schwenkreis P, Nicolas V, Maier C. Sensorimotor retuning [corrected] in complex regional pain syndrome parallels pain reduction. Ann Neurol. 2005 Mar;57(3):425-9. [PubMed: 15732114]]
[41.Misidou C, Papagoras C. Complex Regional Pain Syndrome: An update. Mediterr J Rheumatol. 2019 Mar;30(1):16-25. [PMC free article: PMC7045919] [PubMed: 32185338]]
[42.Terkelsen AJ, Mølgaard H, Hansen J, Finnerup NB, Krøner K, Jensen TS. Heart rate variability in complex regional pain syndrome during rest and mental and orthostatic stress. Anesthesiology. 2012 Jan;116(1):133-46. [PubMed: 22089824]]
[43.Halicka M, Vittersø AD, Proulx MJ, Bultitude JH. Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS). Behav Neurol. 2020;2020:4561831. [PMC free article: PMC7201816] [PubMed: 32399082]]
[44.Libon DJ, Schwartzman RJ, Eppig J, Wambach D, Brahin E, Peterlin BL, Alexander G, Kalanuria A. Neuropsychological deficits associated with Complex Regional Pain Syndrome. J Int Neuropsychol Soc. 2010 May;16(3):566-73. [PubMed: 20298641]]
[45.Park JY, Ahn RS. Hypothalamic-pituitary-adrenal axis function in patients with complex regional pain syndrome type 1. Psychoneuroendocrinology. 2012 Sep;37(9):1557-68. [PubMed: 22445364]]
[46.Irwin DJ, Schwartzman RJ. Complex regional pain syndrome with associated chest wall dystonia: a case report. J Brachial Plex Peripher Nerve Inj. 2011 Sep 26;6:6. [PMC free article: PMC3189858] [PubMed: 21943053]]
[47.Schwartzman RJ, Erwin KL, Alexander GM. The natural history of complex regional pain syndrome. Clin J Pain. 2009 May;25(4):273-80. [PubMed: 19590474]]
[48.Chancellor MB, Shenot PJ, Rivas DA, Mandel S, Schwartzman RJ. Urological symptomatology in patients with reflex sympathetic dystrophy. J Urol. 1996 Feb;155(2):634-7. [PubMed: 8558679]]
[49.Lee JW, Lee SK, Choy WS. Complex Regional Pain Syndrome Type 1: Diagnosis and Management. J Hand Surg Asian Pac Vol. 2018 Mar;23(1):1-10. [PubMed: 29409405]]
[50.Nijs J, Kosek E, Van Oosterwijck J, Meeus M. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise? Pain Physician. 2012 Jul;15(3 Suppl):ES205-13. [PubMed: 22786458]]
[51.Moseley GL, Flor H. Targeting cortical representations in the treatment of chronic pain: a review. Neurorehabil Neural Repair. 2012 Jul-Aug;26(6):646-52. [PubMed: 22331213]]
[52.O’Connell NE, Wand BM, McAuley J, Marston L, Moseley GL. Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD009416. [PMC free article: PMC6469537] [PubMed: 23633371]]
[53.Kalita J, Vajpayee A, Misra UK. Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. QJM. 2006 Feb;99(2):89-95. [PubMed: 16428335]]
[54.Kalita J, Misra U, Kumar A, Bhoi SK. Long-term Prednisolone in Post-stroke Complex Regional Pain Syndrome. Pain Physician. 2016 Nov-Dec;19(8):565-574. [PubMed: 27906935]]
[55.Varenna M, Adami S, Sinigaglia L. Bisphosphonates in Complex Regional Pain syndrome type I: how do they work? Clin Exp Rheumatol. 2014 Jul-Aug;32(4):451-4. [PubMed: 24959990]]
[56.Chevreau M, Romand X, Gaudin P, Juvin R, Baillet A. Bisphosphonates for treatment of Complex Regional Pain Syndrome type 1: A systematic literature review and meta-analysis of randomized controlled trials versus placebo. Joint Bone Spine. 2017 Jul;84(4):393-399. [PubMed: 28408275]]
[57.Brown S, Johnston B, Amaria K, Watkins J, Campbell F, Pehora C, McGrath P. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children. Scand J Pain. 2016 Oct;13:156-163. [PubMed: 28850523]]
[58.Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, Barthel J, Costa B, Graciosa JR, Bruehl S., Reflex Sympathetic Dystrophy Syndrome Association. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med. 2013 Feb;14(2):180-229. [PubMed: 23331950]]
[59.O’Connell NE, Wand BM, Gibson W, Carr DB, Birklein F, Stanton TR. Local anaesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev. 2016 Jul 28;7(7):CD004598. [PMC free article: PMC7202132] [PubMed: 27467116]]
[60.Huygen FJPM, Kallewaard JW, Nijhuis H, Liem L, Vesper J, Fahey ME, Blomme B, Morgalla MH, Deer TR, Capobianco RA. Effectiveness and Safety of Dorsal Root Ganglion Stimulation for the Treatment of Chronic Pain: A Pooled Analysis. Neuromodulation. 2020 Feb;23(2):213-221. [PMC free article: PMC7079258] [PubMed: 31730273]]
[61.Deer TR, Levy RM, Kramer J, Poree L, Amirdelfan K, Grigsby E, Staats P, Burton AW, Burgher AH, Obray J, Scowcroft J, Golovac S, Kapural L, Paicius R, Kim C, Pope J, Yearwood T, Samuel S, McRoberts WP, Cassim H, Netherton M, Miller N, Schaufele M, Tavel E, Davis T, Davis K, Johnson L, Mekhail N. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain. 2017 Apr;158(4):669-681. [PMC free article: PMC5359787] [PubMed: 28030470]]
[62.Bruehl S, Harden RN, Galer BS, Saltz S, Backonja M, Stanton-Hicks M. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain. 2002 Jan;95(1-2):119-24. [PubMed: 11790474]]
[63.Evaniew N, McCarthy C, Kleinlugtenbelt YV, Ghert M, Bhandari M. Vitamin C to Prevent Complex Regional Pain Syndrome in Patients With Distal Radius Fractures: A Meta-Analysis of Randomized Controlled Trials. J Orthop Trauma. 2015 Aug;29(8):e235-41. [PubMed: 26197022]]
[64.Aïm F, Klouche S, Frison A, Bauer T, Hardy P. Efficacy of vitamin C in preventing complex regional pain syndrome after wrist fracture: A systematic review and meta-analysis. Orthop Traumatol Surg Res. 2017 May;103(3):465-470. [PubMed: 28274883]]